Heated Humidified Oxygen Compared to Dry Oxygen Therapy in Children With Bronchiolitis
Status: | Completed |
---|---|
Conditions: | Bronchitis |
Therapuetic Areas: | Pulmonary / Respiratory Diseases |
Healthy: | No |
Age Range: | Any |
Updated: | 1/10/2018 |
Start Date: | January 2014 |
End Date: | June 2015 |
HHOT AIR Study (a Pilot Study): Heated Humidified Oxygen Therapy Compared to Standard Dry Oxygen: An Assessment in Infants With bRonchiolitis
The purpose of this study is to compare heat and humidified oxygen with cold and dry oxygen
in children with bronchiolitis.
The hypotheses are that heating and humidifying inspired low flow supplemental oxygen will
optimize mucociliary function thereby, 1) improve oxygenation, 2) decrease work of breathing,
and 3) decrease length of hospital stay.
in children with bronchiolitis.
The hypotheses are that heating and humidifying inspired low flow supplemental oxygen will
optimize mucociliary function thereby, 1) improve oxygenation, 2) decrease work of breathing,
and 3) decrease length of hospital stay.
Bronchiolitis is the leading cause of acute respiratory illness and hospitalization in
infants and young children. The mainstay of treatment is supportive care, which includes
frequent nasal suctioning, intravenous fluid hydration, and supplemental oxygen for
hypoxemia.
The airways normally heat and humidify inspired ambient air to core temperature amd 100%
relative humidity at the carina. This environment, at core temperature, allows for optimal
mucociliary clearance. Supplemental oxygen delivered via wall source is cold and dry, and
does not reach core temperature and 100% humidity until some point distal to the carina, past
the main bronchi. This presses on the lower respiratory tract to assist in heat and moisture
exchange and thus decrease ciliary function. This, in combination with bronchiolitis, can
impair mucociliary clearance.
Specific aim 1: Determine the effect of heated and humidified oxygen therapy on clinical
improvement in children with bronchiolitis, based on Respiratory Distress Assessment
Instrument (RDAI) and respiratory rate (RR).
Specific aim 2: Determine the effect of heated and humidified oxygen therapy on length of
hospital stay and duration of supplemental oxygen requirement in children with bronchiolitis.
infants and young children. The mainstay of treatment is supportive care, which includes
frequent nasal suctioning, intravenous fluid hydration, and supplemental oxygen for
hypoxemia.
The airways normally heat and humidify inspired ambient air to core temperature amd 100%
relative humidity at the carina. This environment, at core temperature, allows for optimal
mucociliary clearance. Supplemental oxygen delivered via wall source is cold and dry, and
does not reach core temperature and 100% humidity until some point distal to the carina, past
the main bronchi. This presses on the lower respiratory tract to assist in heat and moisture
exchange and thus decrease ciliary function. This, in combination with bronchiolitis, can
impair mucociliary clearance.
Specific aim 1: Determine the effect of heated and humidified oxygen therapy on clinical
improvement in children with bronchiolitis, based on Respiratory Distress Assessment
Instrument (RDAI) and respiratory rate (RR).
Specific aim 2: Determine the effect of heated and humidified oxygen therapy on length of
hospital stay and duration of supplemental oxygen requirement in children with bronchiolitis.
Inclusion Criteria:
- Ages ≤24 months of age
- Physician diagnosed bronchiolitis
- Admitted to pediatric floor
- Supplemental oxygen requirement, <4 L/min, for hypoxemia, oxygen saturation <92% in
room air
Exclusion Criteria:
- Prematurity, born <37 weeks gestational age
- Admitted to pediatric intensive care unit for medical indication
- Requirement of heated, humidified high flow system
- Chronic lung disease (such as bronchopulmonary dysplasia, cystic fibrosis, primary
ciliary dyskinesia, tracheostomy status, baseline oxygen requirement)
- Neuromuscular disorders
- Chromosomal defects
- Metabolic disorders
- Immunodeficiency
- Unrepaired cardiac abnormalities
We found this trial at
1
site
747 52nd St
Oakland, California 94609
Oakland, California 94609
(510) 428-3000
Children's Hospital and Research Center Oakland For nearly 100 years, Children's Hospital & Research Center...
Click here to add this to my saved trials